ACSL4 and neoplasm: Studies have shown that SNPS are more frequent than insertions or deletions in SKCM, and patients with characteristic mutants in the high TMB group have poor survival outcomes and inhibit immune infiltration levels (Cao et al., 2019).These results suggest that ACSL4 may influence the level of tumor immune cell infiltration and ultimately affect patient survival, providing a reference for immunotherapy.